ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 10, October 2026 | pp. 756–763
DOI: 10.46882/AJIDR/149012
Article Type: Research Article
Title: Molecular characterization and benznidazole treatment response in chronic Trypanosoma cruzi Chagas cardiomyopathy
Names of Authors: Valentina Rojas¹*, Babatunde Ojo², Anders Lindqvist³
Abstract: Chagas disease caused by the protozoan parasite Trypanosoma cruzi leads to progressive dilated cardiomyopathy and conduction abnormalities decades after initial infection. We evaluated discrete typing unit distribution, parasitemia clearance, and cardiac biomarker trajectories following benznidazole therapy. Peripheral blood samples from 148 seropositive adults were analyzed via satellite DNA quantitative polymerase chain reaction and echocardiography. Discrete typing units TcII and TcV predominated, with sustained parasitological clearance achieved in 81.8 percent of treated patients at 12 months. Antitrypanosomal chemotherapy halts parasitemia and slows myocardial progression.
Keywords: Trypanosoma cruzi, Chagas cardiomyopathy, Benznidazole, Discrete typing units, Neglected tropical diseases
Citation: Rojas V, Ojo B, Lindqvist A (2026). Molecular characterization and benznidazole treatment response in chronic Trypanosoma cruzi Chagas cardiomyopathy. African Journal of Infectious Diseases Research, 13(10): 756–763. DOI: 10.46882/AJIDR/149012
Manuscript Timeline: Received: August 29, 2026; Revised: September 27, 2026; Accepted: October 19, 2026; Published: October 26, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read